Detalhe da pesquisa
1.
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer.
Cancer
; 126(20): 4485-4497, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32757302
2.
Discontinuation of disease-modifying anti-rheumatic drugs and clinical outcomes in the Rheumatoid Arthritis DMARD Intervention and Utilisation Study 2 (RADIUS 2).
Clin Exp Rheumatol
; 33(3): 297-301, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25738333
3.
Predicting low disease activity and remission using early treatment response to antitumour necrosis factor therapy in patients with rheumatoid arthritis: exploratory analyses from the TEMPO trial.
Ann Rheum Dis
; 71(2): 206-12, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21998118
4.
A novel electromechanical autoinjector, AutoTouch™, for self-injection of etanercept: real-world use and benefits.
Postgrad Med
; 129(1): 118-125, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27829325
5.
The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis.
Clin Rheumatol
; 35(12): 3045-3052, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27704313
6.
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy.
Springerplus
; 4: 113, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25793152
7.
Malignancies in children and young adults on etanercept: summary of cases from clinical trials and post marketing reports.
Pediatr Rheumatol Online J
; 11(1): 35, 2013 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-24225257
8.
Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States.
Arthritis Care Res (Hoboken)
; 65(10): 1564-72, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23554320
9.
Minimally important difference of Health Assessment Questionnaire in psoriatic arthritis: relating thresholds of improvement in functional ability to patient-rated importance and satisfaction.
J Rheumatol
; 38(11): 2461-5, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21885498